Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DTX-P7, a peptide–drug conjugate, is highly effective for non-small cell lung cancer
Yao Jiang, Wei Huang, Xiaojiao Sun, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

Peptide-functionalized, -assembled and -loaded nanoparticles in cancer therapy
Jingyuan Dai, Milad Ashrafizadeh, Amir R. Aref, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 103981-103981
Closed Access | Times Cited: 68
Peptide-drug conjugates: A new paradigm for targeted cancer therapy
Mo Wang, Jiawei Liu, Mingjing Xia, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116119-116119
Closed Access | Times Cited: 32
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Wen‐Jing Xiao, Wenjie Jiang, Zheng Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
Mo Wu, Wei Huang, Nan Yang, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 39
Targeting Peptides: The New Generation of Targeted Drug Delivery Systems
Biagio Todaro, Elisa Ottalagana, Stefano Luin, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1648-1648
Open Access | Times Cited: 36
Small Molecule‐Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs
Jingjing Zhang, Fanchun Hu, Ömer Aras, et al.
ChemMedChem (2024) Vol. 19, Iss. 11
Closed Access | Times Cited: 10
Biological Activity of Natural and Synthetic Peptides as Anticancer Agents
Luana Vittoria Bauso, Valeria La Fauci, S. Munaò, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7264-7264
Open Access | Times Cited: 10
Cancer quiescence: non-coding RNAs in the spotlight
Konstantinos Soureas, M. Papadimitriou, Konstantina Panoutsopoulou, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 10, pp. 843-858
Closed Access | Times Cited: 13
Antimicrobial peptides as drugs with double response against Mycobacterium tuberculosis coinfections in lung cancer
Giulia Polinário, Laura Maria Duran Gleriani Primo, Maiara Alane Baraldi Cerquetani Rosa, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 12
Peptide-driven strategies against lung cancer
Vijayshree S Karankar, Saurabh Awasthi, Nidhi Srivastava
Life Sciences (2025), pp. 123453-123453
Closed Access
Peptide–Drug Conjugates as Next-Generation Therapeutics: Exploring the Potential and Clinical Progress
Krishna Jadhav, Ashwin Abhang, Eknath Kole, et al.
Bioengineering (2025) Vol. 12, Iss. 5, pp. 481-481
Open Access
Novel Co-Delivery System of Curcumin and Docetaxel Using FoF1-ATPase Motor-Embedded Chromatophore Nanorobot for Enhanced Cancer Therapy
Bang Lou, Weiyong Hong, Ying Gao, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106983-106983
Closed Access
Peptides as innovative strategies to combat drug resistance in cancer therapy
Henry Lamb, Aurélie H. Benfield, Sónia Troeira Henriques
Drug Discovery Today (2024) Vol. 29, Iss. 12, pp. 104206-104206
Open Access | Times Cited: 3
Recent advances and applications of peptide–agent conjugates for targeting tumor cells
Vahab Alamdari-Palangi, Khojaste Rahimi Jaberi, Mahshid Shahverdi, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 16, pp. 15249-15273
Closed Access | Times Cited: 7
Increasing monocytes after lung cancer surgery triggers the outgrowth of distant metastases, causing recurrence
Yo Kawaguchi, Keigo Okamoto, Yoko Kataoka, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 11
Open Access | Times Cited: 2
Self-assembled peptide-paclitaxel nanoparticles for enhancing therapeutic efficacy in colorectal cancer
Lidan Hou, Ting Zhong, Peng Cheng, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 9
Reduction‐Responsive RGD‐Docetaxel Conjugate: Synthesis, In Vitro Drug Release and In Vitro Antitumor Activity
Qingqing Li, Yufeng Liu, Yi‐Lin Cheng, et al.
Drug Development Research (2024) Vol. 86, Iss. 1
Closed Access | Times Cited: 1
Targeting the SOX2/CDP protein complex with a peptide suppresses the malignant progression of esophageal squamous cell carcinoma
Yunyun Chen, Kun Zhang, Rui Zhang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Extracellular Vesicle-Based Drug Delivery Systems for Head and Neck Squamous Cell Carcinoma: A Systematic Review
Karolina Dżaman, Katarzyna Czerwaty
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1327-1327
Open Access | Times Cited: 2
Increasing monocytes after lung cancer surgery triggers the outgrowth of distant metastases, causing recurrence
Yo Kawaguchi, Keigo Okamoto, Yoko Kataoka, et al.
Research Square (Research Square) (2024)
Open Access
Cancer Cells in Sleep Mode: Wake Them to Eliminate or Keep Them Asleep Forever?
Wenjie Liu, Antal H. Kovacs, Jinqiang Hou
Cells (2024) Vol. 13, Iss. 23, pp. 2022-2022
Open Access
Page 1

Scroll to top